Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 1
2014 1
2015 1
2017 3
2018 2
2019 7
2020 7
2021 8
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Cremolini C, Antoniotti C, Rossini D, Lonardi S, Loupakis F, Pietrantonio F, Bordonaro R, Latiano TP, Tamburini E, Santini D, Passardi A, Marmorino F, Grande R, Aprile G, Zaniboni A, Murgioni S, Granetto C, Buonadonna A, Moretto R, Corallo S, Cordio S, Antonuzzo L, Tomasello G, Masi G, Ronzoni M, Di Donato S, Carlomagno C, Clavarezza M, Ritorto G, Mambrini A, Roselli M, Cupini S, Mammoliti S, Fenocchio E, Corgna E, Zagonel V, Fontanini G, Ugolini C, Boni L, Falcone A; GONO Foundation Investigators. Cremolini C, et al. Among authors: latiano tp. Lancet Oncol. 2020 Apr;21(4):497-507. doi: 10.1016/S1470-2045(19)30862-9. Epub 2020 Mar 9. Lancet Oncol. 2020. PMID: 32164906 Free article. Clinical Trial.
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer.
Ciardiello D, Martini G, Famiglietti V, Napolitano S, De Falco V, Troiani T, Latiano TP, Ros J, Elez Fernandez E, Vitiello PP, Maiello E, Ciardiello F, Martinelli E. Ciardiello D, et al. Among authors: latiano tp. Cancers (Basel). 2021 Apr 17;13(8):1941. doi: 10.3390/cancers13081941. Cancers (Basel). 2021. PMID: 33920531 Free PMC article. Review.
Combined modality treatments in pancreatic cancer.
Lombardi L, Troiano M, Silvestris N, Nanni L, Latiano TP, Di Maggio G, Cinieri S, Di Sebastiano P, Colucci G, Maiello E. Lombardi L, et al. Among authors: latiano tp. Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S71-81. doi: 10.1517/14728222.2012.662959. Epub 2012 Mar 23. Expert Opin Ther Targets. 2012. PMID: 22443336 Review.
The potential role of nintedanib in treating colorectal cancer.
Rossi A, Latiano TP, Parente P, Chiarazzo C, Limosani F, Di Maggio G, Maiello E. Rossi A, et al. Among authors: latiano tp. Expert Opin Pharmacother. 2017 Aug;18(11):1153-1162. doi: 10.1080/14656566.2017.1346086. Epub 2017 Jul 6. Expert Opin Pharmacother. 2017. PMID: 28649871 Review.
Chemokine receptor CXCR4: role in gastrointestinal cancer.
Lombardi L, Tavano F, Morelli F, Latiano TP, Di Sebastiano P, Maiello E. Lombardi L, et al. Among authors: latiano tp. Crit Rev Oncol Hematol. 2013 Dec;88(3):696-705. doi: 10.1016/j.critrevonc.2013.08.005. Epub 2013 Aug 28. Crit Rev Oncol Hematol. 2013. PMID: 24120239 Review.
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature.
Lombardi P, Rossini D, Crespi V, Germani MM, Bergamo F, Pietrantonio F, Santini D, Allegrini G, Daniel F, Pagani F, Antoniotti C, Zaniboni A, Conca V, Latiano TP, Boccaccino A, Passardi A, Tamburini E, Masi G, Di Maio M, Cremolini C. Lombardi P, et al. Among authors: latiano tp. Cancer Treat Rev. 2022 Feb;103:102326. doi: 10.1016/j.ctrv.2021.102326. Epub 2021 Dec 23. Cancer Treat Rev. 2022. PMID: 35016085 Review.
Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches.
Parente P, Parcesepe P, Covelli C, Olivieri N, Remo A, Pancione M, Latiano TP, Graziano P, Maiello E, Giordano G. Parente P, et al. Among authors: latiano tp. Gastroenterol Res Pract. 2018 Dec 18;2018:7530619. doi: 10.1155/2018/7530619. eCollection 2018. Gastroenterol Res Pract. 2018. PMID: 30662458 Free PMC article. Review.
28 results